Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT03717883Completed
ADPKD Alterations in Hepatic Transporter Function
ADPKDAutosomal Dominant Polycystic Kidney DiseaseRenal Disease
PrincipalinvestigatorStart date: 2018-09-17
NCT02599532Phase 1Completed
Pharmacokinetics of Apixaban in Nephrotic Syndrome
Nephrotic SyndromeProteinuria
StudydirectorStart date: 2017-04-30

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Kim Brouwer, PharmD, PhD

University of North Carolina, Chapel Hill

Moderately Similar
1 trials

Shared therapeutic areas:

Polycystic Kidney, Autosomal DominantAutosomal Dominant Polycystic Kidney DiseaseRenal Disease

Worked with same sponsors:

National Institute of General Medical Sciences (NIGMS)University of North Carolina, Chapel Hill
Collaborated on 1 trial
Similarity Score34%

Daniel Crona, PharmD, PhD

University of North Carolina, Chapel Hill

Related
3 trials

Shared therapeutic areas:

Nephrotic SyndromeProteinuria

Worked with same sponsors:

North Carolina Translational and Clinical Sciences InstituteUniversity of North Carolina, Chapel Hill
Collaborated on 1 trial
Similarity Score24%

Jon Blumenfeld, MD

The Rogosin Institute

Related
4 trials

Shared therapeutic areas:

Polycystic Kidney, Autosomal DominantAutosomal Dominant Polycystic Kidney Disease
Similarity Score12%

Giuseppe Remuzzi, MD

Istituto Di Ricerche Farmacologiche Mario Negri

Related
11 trials

Shared therapeutic areas:

Nephrotic SyndromePolycystic Kidney, Autosomal Dominant
Similarity Score12%

John Neylan, MD

Angion Biomedica

Related
4 trials

Shared therapeutic areas:

Proteinuria
Similarity Score6%

Jin li Zhang, MD

Department of nephrology, People's Hospital of Yunnan Province

Related
2 trials

Shared therapeutic areas:

Nephrotic Syndrome
Similarity Score6%

Mary Ann McLaughlin, MD, MPH

Icahn School of Medicine at Mount Sinai

Related
4 trials

Shared therapeutic areas:

Renal Disease
Similarity Score6%

Junzhou Fu, MD

Department of Nephrology,1st People's Hospital of Guangzhou

Related
2 trials

Shared therapeutic areas:

Nephrotic Syndrome
Similarity Score6%

Yair Lotan, MD

University of Texas Southwestern Medical Center

Related
10 trials

Shared therapeutic areas:

Renal Disease
Similarity Score6%

Yannick Le meur, MD PhD

University Hospital, Brest

Related
4 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03717883PrincipalInvestigator

ADPKD Alterations in Hepatic Transporter Function

ADPKDAutosomal Dominant Polycystic Kidney DiseaseRenal Disease
Completed
NCT02599532Phase 1StudyDirector

Pharmacokinetics of Apixaban in Nephrotic Syndrome

Nephrotic SyndromeProteinuria
Completed

All 2 trials loaded